_id
6913084eccc777a4e85d7b50
Ticker
JUNS
Name
Jupiter Neurosciences, Inc. Common Stock
Exchange
NASDAQ
Address
1001 North US Highway 1, Jupiter, FL, United States, 33477
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://jupiterneurosciences.com
Description
Jupiter Neurosciences, Inc., a clinical stage research and development pharmaceutical company, develops resveratrol platform products for the treatment of neuroinflammation. The company develops JNS101, which is in Phase II trial for the treatment of Friedreich's Ataxia, a rare inherited disease that causes damage to the nervous system, as well as mobility dysfunctions; and JNS108 that is in Phase II trial for treating mild cognitive impairment/early Alzheimer's disease. It is also involved in the development of JNS102, which is in Phase II trial for the treatment of mucopolysaccharidosis type 1; and JNS107 that is in Phase II trial for treating mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes syndrome. In addition, the company develops JNS115, which is in Phase IIa trial for the treatment of Parkinson's disease. It has a strategic partnership with Zina Biopharmaceuticals, LLC to advance Phase 2a clinical trial to evaluate the safety, tolerability, and pharmacokinetics of Resveratrol (JOTROLTM) in individuals with Parkinson's disease; and with Aquanova AG to develop a series of consumer-focused nutritional products targeting longevity, aging, and healthspan. The company was formerly known as Jupiter Orphan Therapeutics, Inc. and changed its name to Jupiter Neurosciences, Inc. in August 2021. Jupiter Neurosciences, Inc. was incorporated in 2016 and is headquartered in Jupiter, Florida.
Last Close
1
Volume
32573
Current Price
1.05
Change
-0.01
Last Updated
2026-01-04T15:50:46.010Z
Image
data:image/webp;base64,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
Ipo Date
2024-12-03T00:00:00.000Z
Market Cap
34770620
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.965
Sentiment Sources
1
Rating
5
Target Price
30
Strong Buy
1
Buy
0
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
2297053
Operating Income
-2297053
Interest Expense
1193
Pretax Income
-2288034
Net Income
-2288034
Eps
-0.06721622556772043
Dividends Per Share
-
Shares Outstanding
34426355
Income Tax Expense
-
EBITDA
-2286841
Operating Margin
-
Total Other Income Expense Net
9019
Cash
723797
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
1632358
Property Plant Equipment
34821
Total Assets
2576259
Payables
478352
Short Term Debt
180393
Long Term Debt
-
Total Liabilities
2518842
Equity
57417
Bs_currency_symbol
USD
Depreciation
-
Change In Working Capital
-64990
Cash From Operations
-1154450
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
0
Net Change In Cash
-1154450
Cf_currency_symbol
USD
PE
-
PB
622.4968441402373
ROE
-3984.9417419927895
ROA
-88.81226615802215
FCF
-1154450
Fcf Percent
-
Piotroski FScore
1
Health Score
17
Deep Value Investing Score
1.5
Defensive Investing Score
5
Dividend Investing Score
1
Economic Moat Investing Score
2.8
Garp Investing Score
0.5
Growth Investing Score
0.5
Momentum Investing Score
2.5
Net Net Investing Score
1
Quality Investing Score
1
Value Investing Score
1.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
2297053
Quarters > 0 > income Statement > operating Income
-2297053
Quarters > 0 > income Statement > interest Expense
1193
Quarters > 0 > income Statement > pretax Income
-2288034
Quarters > 0 > income Statement > net Income
-2288034
Quarters > 0 > income Statement > eps
-0.06721622556772043
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
34039906
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-2286841
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
9019
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
723797
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
1632358
Quarters > 0 > balance Sheet > property Plant Equipment
34821
Quarters > 0 > balance Sheet > total Assets
2576259
Quarters > 0 > balance Sheet > payables
478352
Quarters > 0 > balance Sheet > short Term Debt
180393
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
2518842
Quarters > 0 > balance Sheet > equity
57417
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-2288034
Quarters > 0 > cash Flow > depreciation
-
Quarters > 0 > cash Flow > change In Working Capital
-64990
Quarters > 0 > cash Flow > cash From Operations
-1154450
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
0
Quarters > 0 > cash Flow > net Change In Cash
-1154450
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.06721622556772043
Quarters > 0 > ratios > PB
622.4968441402373
Quarters > 0 > ratios > ROE
-3984.9417419927895
Quarters > 0 > ratios > ROA
-88.81226615802215
Quarters > 0 > ratios > FCF
-1154450
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
17
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
2264880
Quarters > 1 > income Statement > operating Income
-2264880
Quarters > 1 > income Statement > interest Expense
1135
Quarters > 1 > income Statement > pretax Income
-2252965
Quarters > 1 > income Statement > net Income
-2252965
Quarters > 1 > income Statement > eps
-0.06789931914580184
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
33180966
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-2251830
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
11915
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
1878247
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
2819132
Quarters > 1 > balance Sheet > property Plant Equipment
46649
Quarters > 1 > balance Sheet > total Assets
3968103
Quarters > 1 > balance Sheet > payables
465093
Quarters > 1 > balance Sheet > short Term Debt
192860
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
2627985
Quarters > 1 > balance Sheet > equity
1340118
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-2252965
Quarters > 1 > cash Flow > depreciation
-
Quarters > 1 > cash Flow > change In Working Capital
705114
Quarters > 1 > cash Flow > cash From Operations
-828222
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
0
Quarters > 1 > cash Flow > net Change In Cash
-828222
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.06789931914580184
Quarters > 1 > ratios > PB
25.997721320062862
Quarters > 1 > ratios > ROE
-168.1169120928157
Quarters > 1 > ratios > ROA
-56.776878019547375
Quarters > 1 > ratios > FCF
-828222
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
25
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
1538003
Quarters > 2 > income Statement > operating Income
-1538003
Quarters > 2 > income Statement > interest Expense
1229
Quarters > 2 > income Statement > pretax Income
-1528867
Quarters > 2 > income Statement > net Income
-1528867
Quarters > 2 > income Statement > eps
-0.04618394954546086
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
33103860
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-1527638
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
9136
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
2706469
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
3611328
Quarters > 2 > balance Sheet > property Plant Equipment
58035
Quarters > 2 > balance Sheet > total Assets
4962826
Quarters > 2 > balance Sheet > payables
158483
Quarters > 2 > balance Sheet > short Term Debt
196988
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
1898231
Quarters > 2 > balance Sheet > equity
3064595
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-1528867
Quarters > 2 > cash Flow > depreciation
-
Quarters > 2 > cash Flow > change In Working Capital
-144669
Quarters > 2 > cash Flow > cash From Operations
-1063041
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
0
Quarters > 2 > cash Flow > net Change In Cash
-1063041
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-0.04618394954546086
Quarters > 2 > ratios > PB
11.342135910291573
Quarters > 2 > ratios > ROE
-49.88806024939674
Quarters > 2 > ratios > ROA
-30.80637926858608
Quarters > 2 > ratios > FCF
-1063041
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
31
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
0
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
1458356
Quarters > 3 > income Statement > operating Income
-1458356
Quarters > 3 > income Statement > interest Expense
30545
Quarters > 3 > income Statement > pretax Income
-1527627
Quarters > 3 > income Statement > net Income
-1527627
Quarters > 3 > income Statement > eps
-0.053073849552748846
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
28783045
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-1497082
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
-69271
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
3769510
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
4650263
Quarters > 3 > balance Sheet > property Plant Equipment
69642
Quarters > 3 > balance Sheet > total Assets
6202409
Quarters > 3 > balance Sheet > payables
278676
Quarters > 3 > balance Sheet > short Term Debt
196514
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
2030401
Quarters > 3 > balance Sheet > equity
4172008
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-1527627
Quarters > 3 > cash Flow > depreciation
43288
Quarters > 3 > cash Flow > change In Working Capital
-3358735
Quarters > 3 > cash Flow > cash From Operations
-3695779
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
7465036
Quarters > 3 > cash Flow > net Change In Cash
3769257
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.053073849552748846
Quarters > 3 > ratios > PB
7.244041058885793
Quarters > 3 > ratios > ROE
-36.61610907745143
Quarters > 3 > ratios > ROA
-24.629575379501738
Quarters > 3 > ratios > FCF
-3695779
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
34
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
-
Annuals > 0 > income Statement > operating Expenses
3091282
Annuals > 0 > income Statement > operating Income
-3091282
Annuals > 0 > income Statement > interest Expense
248366
Annuals > 0 > income Statement > pretax Income
-2439625
Annuals > 0 > income Statement > net Income
-2439625
Annuals > 0 > income Statement > eps
-0.08475910036620517
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
28783045
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-2191259
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
651657
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
3769510
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
4650263
Annuals > 0 > balance Sheet > property Plant Equipment
69642
Annuals > 0 > balance Sheet > total Assets
6202409
Annuals > 0 > balance Sheet > payables
278676
Annuals > 0 > balance Sheet > short Term Debt
196514
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
2030401
Annuals > 0 > balance Sheet > equity
4172008
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-2439625
Annuals > 0 > cash Flow > depreciation
43288
Annuals > 0 > cash Flow > change In Working Capital
-2565721
Annuals > 0 > cash Flow > cash From Operations
-3911004
Annuals > 0 > cash Flow > capital Expenditures
4
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
7652036
Annuals > 0 > cash Flow > net Change In Cash
3741032
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-0.08475910036620517
Annuals > 0 > ratios > PB
6.968077589975858
Annuals > 0 > ratios > ROE
-58.4760383968583
Annuals > 0 > ratios > ROA
-39.333507351740266
Annuals > 0 > ratios > FCF
-3911008
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
27
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
-
Annuals > 1 > income Statement > gross Profit
-
Annuals > 1 > income Statement > operating Expenses
3870771
Annuals > 1 > income Statement > operating Income
-3870771
Annuals > 1 > income Statement > interest Expense
218705
Annuals > 1 > income Statement > pretax Income
-4783689
Annuals > 1 > income Statement > net Income
-4783689
Annuals > 1 > income Statement > eps
-0.14550519851420532
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
32876413
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-4564984
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
-912918
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
28478
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
28739
Annuals > 1 > balance Sheet > property Plant Equipment
116070
Annuals > 1 > balance Sheet > total Assets
148592
Annuals > 1 > balance Sheet > payables
189495
Annuals > 1 > balance Sheet > short Term Debt
2070452
Annuals > 1 > balance Sheet > long Term Debt
106712
Annuals > 1 > balance Sheet > total Liabilities
5949944
Annuals > 1 > balance Sheet > equity
-5801352
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-4783689
Annuals > 1 > cash Flow > depreciation
-694213
Annuals > 1 > cash Flow > change In Working Capital
2348250
Annuals > 1 > cash Flow > cash From Operations
-480953
Annuals > 1 > cash Flow > capital Expenditures
3
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
445000
Annuals > 1 > cash Flow > net Change In Cash
-35953
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-0.14550519851420532
Annuals > 1 > ratios > PB
-5.723696326304627
Annuals > 1 > ratios > ROE
82.45817526673093
Annuals > 1 > ratios > ROA
-3219.3449176267904
Annuals > 1 > ratios > FCF
-480956
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
31
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
233281
Annuals > 2 > income Statement > cost Of Revenue
-
Annuals > 2 > income Statement > gross Profit
233281
Annuals > 2 > income Statement > operating Expenses
3665728
Annuals > 2 > income Statement > operating Income
-3432447
Annuals > 2 > income Statement > interest Expense
740854
Annuals > 2 > income Statement > pretax Income
-4957580
Annuals > 2 > income Statement > net Income
-4957580
Annuals > 2 > income Statement > eps
-0.15079443125379888
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
32876413
Annuals > 2 > income Statement > income Tax Expense
-
Annuals > 2 > income Statement > EBITDA
-4216726
Annuals > 2 > income Statement > operating Margin
-1471.3787235137024
Annuals > 2 > income Statement > total Other Income Expense Net
-1525133
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
64431
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
69663
Annuals > 2 > balance Sheet > property Plant Equipment
162498
Annuals > 2 > balance Sheet > total Assets
235944
Annuals > 2 > balance Sheet > payables
187032
Annuals > 2 > balance Sheet > short Term Debt
1778640
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
7380028
Annuals > 2 > balance Sheet > equity
-7144084
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-4957580
Annuals > 2 > cash Flow > depreciation
-784279
Annuals > 2 > cash Flow > change In Working Capital
1548903
Annuals > 2 > cash Flow > cash From Operations
-1248504
Annuals > 2 > cash Flow > capital Expenditures
4
Annuals > 2 > cash Flow > cash From Investing
-
Annuals > 2 > cash Flow > cash From Financing
982333
Annuals > 2 > cash Flow > net Change In Cash
-266171
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-0.15079443125379888
Annuals > 2 > ratios > PB
-4.647926470349453
Annuals > 2 > ratios > ROE
69.39420085206164
Annuals > 2 > ratios > ROA
-2101.168073780219
Annuals > 2 > ratios > FCF
-1248508
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-5.351948937118753
Annuals > 2 > health Score
30
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
638037
Annuals > 3 > income Statement > cost Of Revenue
-
Annuals > 3 > income Statement > gross Profit
638037
Annuals > 3 > income Statement > operating Expenses
4545134
Annuals > 3 > income Statement > operating Income
-3907097
Annuals > 3 > income Statement > interest Expense
113994
Annuals > 3 > income Statement > pretax Income
-4200259
Annuals > 3 > income Statement > net Income
-4379427
Annuals > 3 > income Statement > eps
-0.46163953441672595
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
9486681
Annuals > 3 > income Statement > income Tax Expense
179168
Annuals > 3 > income Statement > EBITDA
-4086265
Annuals > 3 > income Statement > operating Margin
-612.3621357382095
Annuals > 3 > income Statement > total Other Income Expense Net
-293162
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
330602
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
454674
Annuals > 3 > balance Sheet > property Plant Equipment
208926
Annuals > 3 > balance Sheet > total Assets
667383
Annuals > 3 > balance Sheet > payables
256893
Annuals > 3 > balance Sheet > short Term Debt
486800
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
5845013
Annuals > 3 > balance Sheet > equity
-5177630
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-4200259
Annuals > 3 > cash Flow > depreciation
-179168
Annuals > 3 > cash Flow > change In Working Capital
781288
Annuals > 3 > cash Flow > cash From Operations
-1735046
Annuals > 3 > cash Flow > capital Expenditures
4
Annuals > 3 > cash Flow > cash From Investing
-
Annuals > 3 > cash Flow > cash From Financing
1857650
Annuals > 3 > cash Flow > net Change In Cash
122604
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-0.46163953441672595
Annuals > 3 > ratios > PB
-1.850566342129507
Annuals > 3 > ratios > ROE
84.58362223642864
Annuals > 3 > ratios > ROA
-656.2089534794862
Annuals > 3 > ratios > FCF
-1735050
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-2.7193564009610727
Annuals > 3 > health Score
30
Valuation > metrics > PE
-0.06721622556772043
Valuation > metrics > PB
622.4968441402373
Valuation > final Score
20
Valuation > verdict
20649.9% Overvalued
Profitability > metrics > ROE
-3984.9417419927895
Profitability > metrics > ROA
-140.16741425594142
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
43.86927216677987
Risk > metrics > Interest Coverage
-1925.4425817267393
Risk > final Score
-7696
Risk > verdict
High
Liquidity > metrics > Current Ratio
2.4779816165587594
Liquidity > metrics > Quick Ratio
2.4779816165587594
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
20
Prev Valuations > 1
20
Prev Valuations > 2
20
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
15
Prev Risks > 0
-7952
Prev Risks > 1
-4958
Prev Risks > 2
-131
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:04:48.544Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-02-25
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0
Earnings History > 0 > eps Estimate
-0.06
Earnings History > 0 > eps Difference
0.06
Earnings History > 0 > surprise Percent
100
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-12-03
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.07
Earnings History > 1 > eps Estimate
-0.08
Earnings History > 1 > eps Difference
0.01
Earnings History > 1 > surprise Percent
12.5
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-09-03
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.07
Earnings History > 2 > eps Estimate
-0.07
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
0
Earnings History > 3 > period
2025-03-31
Earnings History > 3 > report Date
2025-05-28
Earnings History > 3 > date
2025-03-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.05
Earnings History > 3 > eps Estimate
-0.03
Earnings History > 3 > eps Difference
-0.02
Earnings History > 3 > surprise Percent
-66.6667
Earnings History > 4 > period
2024-12-31
Earnings History > 4 > report Date
2025-02-26
Earnings History > 4 > date
2024-12-31
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
-0.05
Earnings History > 4 > eps Estimate
-0.02
Earnings History > 4 > eps Difference
-0.03
Earnings History > 4 > surprise Percent
-150
Earnings History > 5 > period
2024-09-30
Earnings History > 5 > report Date
2024-11-27
Earnings History > 5 > date
2024-09-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
-
Earnings History > 5 > eps Actual
-0.02
Earnings History > 5 > eps Estimate
-0.02
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
0
Earnings History > 6 > period
2021-12-31
Earnings History > 6 > report Date
2022-01-05
Earnings History > 6 > date
2021-12-31
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
-
Earnings History > 6 > eps Actual
-0.07
Earnings History > 6 > eps Estimate
0
Earnings History > 6 > eps Difference
-0.07
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2021-09-30
Earnings History > 7 > report Date
2021-11-09
Earnings History > 7 > date
2021-09-30
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
-
Earnings History > 7 > eps Actual
-0.03
Earnings History > 7 > eps Estimate
0
Earnings History > 7 > eps Difference
-0.03
Earnings History > 7 > surprise Percent
-
Jupiter Neurosciences, Inc., a clinical stage research and development pharmaceutical company, develops resveratrol platform products for the treatment of neuroinflammation. The company develops JNS101, which is in Phase II trial for the treatment of Friedreich's Ataxia, a rare inherited disease that causes damage to the nervous system, as well as mobility dysfunctions; and JNS108 that is in Phase II trial for treating mild cognitive impairment/early Alzheimer's disease. It is also involved in the development of JNS102, which is in Phase II trial for the treatment of mucopolysaccharidosis type 1; and JNS107 that is in Phase II trial for treating mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes syndrome. In addition, the company develops JNS115, which is in Phase IIa trial for the treatment of Parkinson's disease. It has a strategic partnership with Zina Biopharmaceuticals, LLC to advance Phase 2a clinical trial to evaluate the safety, tolerability, and pharmacokinetics of Resveratrol (JOTROLTM) in individuals with Parkinson's disease; and with Aquanova AG to develop a series of consumer-focused nutritional products targeting longevity, aging, and healthspan. The company was formerly known as Jupiter Orphan Therapeutics, Inc. and changed its name to Jupiter Neurosciences, Inc. in August 2021. Jupiter Neurosciences, Inc. was incorporated in 2016 and is headquartered in Jupiter, Florida.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AWhy JUNS stock attracts global investors - July 2025 Macro Moves & Safe Capital Growth Plans bollywoodhelpline.com
Read more →Will Grupo Bimbo S.A.B. de C.V. (Common Stock) (4GM0) stock outperform value peers - Treasury Yields & Fast Moving Stock Watchlists bollywoodhelpline.com
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$30
Analyst Picks
Strong Buy
1
Buy
0
Hold
0
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Jupiter Neurosciences, Inc. Common Stock
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
-0.06
Date
2025-09-30
EPS Actual
-0.07
EPS Estimate
-0.08
EPS Difference
0.01
Surprise Percent
12.5%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.